Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/05/smr-stock-slides-as-lawsuits-mount-and-analysts-turn-cautious.jpg
https://stockstotrade-nuxt-staging.stockstotrade-com-inc.workers.dev/

SMR Stock Slides As Lawsuits Mount And Analysts Turn Cautious

TIM BOHENUPDATED MAY. 19, 2026, 4:03 PM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

NuScale Power Corporation stocks have been trading down by -3.34 percent after bleak analyst coverage highlighted mounting financial risks.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading SMR

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

  • Class actions accuse NuScale Power of misleading traders about ENTRA1’s qualifications and commercialization risks, with an April 20, 2026 lead‑plaintiff deadline keeping litigation in focus.
  • A $495M payment to ENTRA1 tied to a TVA deal drove a $532M quarterly net loss and preceded SMR’s plunge from above $57 to near $17 in 2025.
  • Rosen Law Firm and others are promoting overlapping fraud suits, signaling persistent headline pressure around SMR’s disclosure practices and deployment strategy.
  • Former strategic backer Fluor has exited its roughly 40M‑share SMR stake via about $2.43B of open‑market sales since 2025.
  • Citi twice cut its SMR target, down to $7 with a Sell rating, while Goldman Sachs trimmed its target to $9 and stayed Neutral, underscoring reduced upside expectations.

Candlestick Chart

Live Update At 16:03:05 EDT: On Tuesday, May 19, 2026 NuScale Power Corporation stock [NYSE: SMR] is trending down by -3.34%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

NuScale Power and its SMR stock are trading under clear financial stress, even though the balance sheet still shows sizable cash. On the tape, SMR has slid from the mid‑$13s in late April to around $10, a roughly 25% pullback in less than a month. The multi‑day chart shows repeated fades on pops above $12–$13, telling traders sellers are still in control on strength.

Intraday, SMR chopped between roughly $9.70 and $10.10, with tight five‑minute candles and little follow‑through. That action screams indecision. Day traders see a liquid range, but not yet a decisive trend reversal.

Fundamentals explain the hesitation. NuScale Power generated just $31.5M in revenue, yet sports a price‑to‑sales ratio over 200. Profitability is deeply negative: EBIT margin is around -2,190%, net margins are more than -1,100%, and returns on equity and assets are sharply in the red. The latest quarter shows only $565,000 in revenue against $58.1M in expenses and a net loss of about $44M.

More Breaking News

SMR does hold roughly $890M in cash and short‑term investments with no long‑term debt, plus a current ratio near 4.3. That gives NuScale Power time, but burn is heavy, so traders are watching every capital‑allocation move and headline closely.

Why Traders Are Watching SMR’s Mounting Risks

NuScale Power’s SMR story has shifted from pure growth hype to a high‑risk clean‑energy litigation play, and that change matters for every trading plan. The core issue is ENTRA1, NuScale’s commercialization partner. Multiple class actions allege NuScale misled the market about ENTRA1’s experience and capabilities, and failed to flag key risks in its deployment strategy.

The complaints point to one monster transaction: a $495M payment to ENTRA1 tied to a TVA agreement. That single charge blew up NuScale Power’s general and administrative line and contributed to a quarterly net loss of $532M. After that, SMR collapsed from above $57 to near $17 by 2025/11. For traders, that is not just a bad quarter. It is a credibility hit that reshaped the chart and the narrative.

Rosen Law Firm and Faruqi & Faruqi both highlight an April 20, 2026 deadline for traders who bought SMR in the 2025 window to seek lead‑plaintiff status. That means at least the next year keeps NuScale Power and ENTRA1 in the legal spotlight. Another suit adds that NuScale’s alleged misstatements exposed its reactor deployment plan to hidden risks of failure, delays, and regulatory setbacks. Translation for traders: timelines and revenue ramps around the NuScale Power Module are more uncertain than the old bull case suggested.

Layer on top the exit of Fluor, which dumped about 40M NuScale Power shares in open‑market sales totaling roughly $2.43B since 2025/09. A long‑time strategic backer walking away is a big sentiment signal. While that selling pressure has now cleared, the message to the market is hard to ignore.

Finally, the sell‑side is recalibrating. Citi first cut its SMR target from $11.50 to $9 with a Sell rating, then again from $9 to $7, signaling that even prior bearish expectations were too optimistic. Goldman Sachs shaved its target from $10 to $9 while staying Neutral. When both bearish and neutral coverage move down together, traders should respect that as a consensus reset on NuScale Power’s upside.

Conclusion

SMR now trades where legal, execution, and valuation risks collide. NuScale Power still has a sizable cash pile and no long‑term debt, so this is not a classic balance‑sheet crisis. The real problem is trust and timing. With class actions attacking NuScale’s disclosures around ENTRA1, and complaints pointing directly at a $495M payment that torched a quarter and preceded a massive share‑price collapse, traders are demanding a much bigger margin of safety.

On the screen, that shows up as a stock stuck near $10 after a hard slide from the teens. SMR’s intraday action is range‑bound, and rallies into the $12–$13 area have been sold repeatedly over the past few weeks. Add in Fluor’s full exit and dual class‑action campaigns, and it is clear why many are treating NuScale Power as a show‑me story.

For active traders, the edge will not come from guessing lawsuit outcomes. It will come from reacting faster than the crowd when new facts hit. That means tracking every NuScale Power filing, every ENTRA1 update, and every analyst move while respecting key technical levels on the SMR chart. As Tim Bohen, lead trainer with StocksToTrade says, “For me, trading is more about managing risk than finding the next big mover.” In a name like SMR, where headlines can shift the tape in minutes, that focus on risk management over chasing home runs becomes even more critical.

Tim Sykes loves to say, “The market doesn’t care about your opinion; it cares about your preparation.” With SMR, that means studying the legal overhang, the cash burn, and the chart together. Use the volatility for educated trades, cut losses fast, and remember this is educational and research content only—not a signal to buy or sell NuScale Power.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders